ADMA fund manager activity
ADMA Biologics Inc · Nasdaq. Reported by 4 tracked fund managers in their 13F filings, Q4 2022 to Q2 2026.
Q2 2026
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|
| Stanley Druckenmiller - Duquesne Family Office | Added | 2,784,110 | $23,303,000 | 0.54% | Aug 14, 2026 |
| Terry Smith - Fundsmith | No change | 1,649,493 | $13,806,256 | 0.10% | Aug 14, 2026 |
| Joel Greenblatt - Gotham Asset Management | New | 73,829 | $617,949 | 0.00% | Aug 14, 2026 |
Q1 2026
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|
| Stanley Druckenmiller - Duquesne Family Office | Added | 1,545,610 | $13,926,000 | 0.47% | May 15, 2026 |
| Terry Smith - Fundsmith | Trimmed | 1,649,493 | $14,861,932 | 0.12% | May 15, 2026 |
| Joel Greenblatt - Gotham Asset Management | Sold out | — | — | 0.00% | May 15, 2026 |
Older quarters